Clinical trial design during and beyond the pandemic: the I-SPY COVID trial-Reference-Cited by-同舟云学术

Clinical trial design during and beyond the pandemic: the I-SPY COVID trial

Published:2022-01 Issue:1 Volume:28 Page:9-11
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

,Calfee Carolyn S.,Liu Kathleen D.,Asare Adam L.,Beitler Jeremy R.^ORCID,Berger Paul A.,Coleman Melissa H.,Crippa Alessio,Discacciati Andrea,Eklund Martin^ORCID,Files Daniel C.,Gandotra Sheetal,Gibbs Kevin W.^ORCID,Henderson Paul,Levitt Joseph E.^ORCID,Lu Ruixiao,Matthay Michael A.^ORCID,Meyer Nuala J.^ORCID,Russell Derek W.,Thomas Karl W.,Esserman Laura J.,Mittel Aaron M.^ORCID,Dzierba Amy L.,Madahar Purnema,Serra Alexis L.,Rosen Amanda,Garcia Ivan,Muir Justin,Schicchi John,Darmanian Anita,Wahab Romina,Gosek Katarzyna,Auld Sara C.,Adelman Max W.,Nugent Katherine L.,Harris Gavin H.,Creel-Bulos Christina^ORCID,Yang Philip^ORCID,Detelich Joshua F.,Spainhour Christine,Cobb Nathan K.,Sonti Rajiv,Orr Lindsey A.,Robinson Philip A.,Sarafian Farjad,Martinez Esmeralda,Jones Patrice,Nguyen Julie,Obermiller Timothy F.,Weiler-Lisowski Bethany,Kufa Lucia,Saba Paul L.,Wyatt Jaime,Youssef Fady A.,Tanios Maged,Blevins Daniel,Macias Laura R.,Suarez Alexis E.,Reyes Maria B.,Jung Michelle,Melendrez Marylee,Rosario-Remigio Lissette,Su Henry,Friedman Eliot B.,Angelucci Christina M.,Chaparro-Rojas Fredy,Sternlieb Mitchell P.,Sutter Jacqueline B.,Whealon Spencer,Nair Rahul,Lopez Brenda,Amosu Omowunmi,Tzehaie Hiwet,Wunderink Richard G.^ORCID,Patel Chirag,Simonson Austin,Dodin Jamal,Oliver Tony,Lupu Roxana A.,Meyers Michelle,Albertson Timothy E.,Haczku Angela^ORCID,Hardy Erin,Morrissey Brian M.,Juarez Maya M.,Pearson Skyler J.^ORCID,Lee Richard Anthony,Amin Alpesh N.,Jauregui Alejandra,Fields Scott,Ng Diana,Daniel Brian M.,Yee Kimberly^ORCID,Jones Chayse,Burnham Ellen L.,McKeehan Jeffrey D.,Ittner Caroline A. G.,Reilly John P.^ORCID,Mangalmurti Nilam S.^ORCID,Rodrigues Laura G.,Weisman Ariel R.^ORCID,Khan Kashif T.,Wong Se Fum,Yen Albert F.,Peterfreund Gregory,Kumar Santhi I.,Marshall Peter S.,Huerta Luis E.^ORCID,Lindgren Brett,Lee Jerry S.^ORCID,Barker Anna D.,Lang Julie E.,LaRose Mary,Landreth Leigha,Parks Lisa,Barot Harsh V.,Koff Jonathan L.,Kazianis John,Boerger Lindsie L., ,

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

https://www.nature.com/articles/s41591-021-01617-x.pdf

Reference9 articles.

1. RECOVERY Collaborative Group. et al. N. Engl. J. Med. 384, 693–704 (2020).

2. RECOVERY Collaborative Group. et al. Lancet 396, 1345–1352 (2020).

3. Abaleke, E. et al. Lancet 397, 605–612 (2021).

4. Angus, D. C. et al. Ann. Am. Thorac. Soc. 17, 879–891 (2020).

5. Writing Committee for the REMAP-CAP Investigators. JAMA 324, 1317–1329 (2020).

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Using Bayesian statistics in confirmatory clinical trials in the regulatory setting: a tutorial review;BMC Medical Research Methodology;2024-05-07

2. SARS-CoV-2 resistance to monoclonal antibodies and small-molecule drugs;Cell Chemical Biology;2024-04

3. Using the ‘Leapfrog’ Design as a Simple Form of Adaptive Platform Trial to Develop, Test, and Implement Treatment Personalization Methods in Routine Practice;Administration and Policy in Mental Health and Mental Health Services Research;2024-02-05

4. How Electronic Medical Record Integration Can Support More Efficient Critical Care Clinical Trials;Critical Care Clinics;2023-10

5. Trend in Clinical Trial Participation During COVID-19: A Secondary Analysis of the I-SPY COVID Clinical Trial;Critical Care Explorations;2023-06